Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chanoch Miodownik

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Israel Journal of Psychiatry and Related Sciences|August 2, 2007
The prevalence of neuroleptic drug-induced tardive movement subsyndromes among schizophrenic and schizoaffective patients residing in the southern region of IsraelVladimir Lerner, Igor Libov, Alexander Kaptsan, et al.
Clinical Neuropharmacology|August 2, 2008
Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesiaChanoch Miodownik, Aviel Meoded, Igor Libov, et al.
Clinical Neuropharmacology|May 26, 2016
Donepezil as Add-on Treatment for Resistant Obsessive-Compulsive Disorder: Retrospective Case SeriesJoseph Bergman, Chanoch Miodownik, Paul P Lerner, et al.
Israel Journal of Health Policy Research|February 2, 2019
Clinical and demographic characteristics of secluded and mechanically restrained mentally ill patients: a retrospective studyChanoch Miodownik, Michael D Friger, Eyal Orev, et al.
Clinical Neuropharmacology|October 24, 2017
Successful Use of Escitalopram for the Treatment of Visual Hallucinations in Patients With Parkinson DiseaseJoseph Bergman, Paul P Lerner, Shmuel Sokolik, et al.
The Journal of Clinical Psychiatry|January 13, 2006
High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesiaVladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al.
Community Mental Health Journal|November 3, 2025
Implementation of a Family-Centered Care Model in Psychiatric Hospitals as a Means of Reducing Caregiver Anxiety: A Comparative StudyRon Shor, Kfir Feffer, Jonathan Guez, et al.
Clinical Neuropharmacology|April 15, 2006
Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled studyChanoch Miodownik, Vladimir Lerner, Nikolay Statsenko, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 23, 2010
Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivationAnatoly Kreinin, Chanoch Miodownik, Shmuel Sokolik, et al.
The Journal of Clinical Psychiatry|January 7, 2011
L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center studyMichael S Ritsner, Chanoch Miodownik, Yael Ratner, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Israel Journal of Psychiatry and Related Sciences|August 2, 2007
The prevalence of neuroleptic drug-induced tardive movement subsyndromes among schizophrenic and schizoaffective patients residing in the southern region of IsraelVladimir Lerner, Igor Libov, Alexander Kaptsan, et al.
Clinical Neuropharmacology|August 2, 2008
Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesiaChanoch Miodownik, Aviel Meoded, Igor Libov, et al.
Clinical Neuropharmacology|May 26, 2016
Donepezil as Add-on Treatment for Resistant Obsessive-Compulsive Disorder: Retrospective Case SeriesJoseph Bergman, Chanoch Miodownik, Paul P Lerner, et al.
Israel Journal of Health Policy Research|February 2, 2019
Clinical and demographic characteristics of secluded and mechanically restrained mentally ill patients: a retrospective studyChanoch Miodownik, Michael D Friger, Eyal Orev, et al.
Clinical Neuropharmacology|October 24, 2017
Successful Use of Escitalopram for the Treatment of Visual Hallucinations in Patients With Parkinson DiseaseJoseph Bergman, Paul P Lerner, Shmuel Sokolik, et al.
The Journal of Clinical Psychiatry|January 13, 2006
High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesiaVladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al.
Community Mental Health Journal|November 3, 2025
Implementation of a Family-Centered Care Model in Psychiatric Hospitals as a Means of Reducing Caregiver Anxiety: A Comparative StudyRon Shor, Kfir Feffer, Jonathan Guez, et al.
Clinical Neuropharmacology|April 15, 2006
Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled studyChanoch Miodownik, Vladimir Lerner, Nikolay Statsenko, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 23, 2010
Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivationAnatoly Kreinin, Chanoch Miodownik, Shmuel Sokolik, et al.
The Journal of Clinical Psychiatry|January 7, 2011
L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center studyMichael S Ritsner, Chanoch Miodownik, Yael Ratner, et al.
Pageof 4